
No. of Pages: 151 | Report Code: BMIRE00030826 | Category: Life Sciences
No. of Pages: 151 | Report Code: BMIRE00030826 | Category: Life Sciences
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. North America Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market - North America Analysis
6.1 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. North America Bioprocessing Market Analysis - by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
8. North America Bioprocessing Market Analysis - by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. North America Bioprocessing Market Analysis - by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. North America Bioprocessing Market Analysis - by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. North America Bioprocessing Market Analysis - by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12. North America Bioprocessing Market - Country Analysis
12.1 North America: Bioprocessing Market Overview
12.1.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Country
12.1.1.1 United States: Bioprocessing Market- Revenue and Forecast to 2031 (US$ Million)
12.1.1.2 Overview
12.1.1.3 United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 United States: Bioprocessing Market Breakdown, by Product
12.1.1.3.1.1 United States: Bioprocessing Market Breakdown, by Instruments
12.1.1.3.1.1.1 United States: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.3.1.1.2 United States: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.3.1.2 United States: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.3.2 United States: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.3.3 United States: Bioprocessing Market Breakdown, by Process
12.1.1.3.4 United States: Bioprocessing Market Breakdown, by Application
12.1.1.3.5 United States: Bioprocessing Market Breakdown, by End User
12.1.1.4 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 Overview
12.1.1.5 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Canada: Bioprocessing Market Breakdown, by Product
12.1.1.5.1.1 Canada: Bioprocessing Market Breakdown, by Instruments
12.1.1.5.1.1.1 Canada: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.5.1.1.2 Canada: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.5.1.2 Canada: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.5.2 Canada: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.5.3 Canada: Bioprocessing Market Breakdown, by Process
12.1.1.5.4 Canada: Bioprocessing Market Breakdown, by Application
12.1.1.5.5 Canada: Bioprocessing Market Breakdown, by End User
12.1.1.6 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 Overview
12.1.1.7 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Mexico: Bioprocessing Market Breakdown, by Product
12.1.1.7.1.1 Mexico: Bioprocessing Market Breakdown, by Instruments
12.1.1.7.1.1.1 Mexico: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.7.1.1.2 Mexico: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.7.1.2 Mexico: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.7.2 Mexico: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.7.3 Mexico: Bioprocessing Market Breakdown, by Process
12.1.1.7.4 Mexico: Bioprocessing Market Breakdown, by Application
12.1.1.7.5 Mexico: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
List of Tables
Table 1. North America Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 35. Recent Organic Growth Strategies in the Bioprocessing Market
Table 36. Glossary of Terms, Bioprocessing Market
List of Figures
Figure 1. North America Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. North America: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. North America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Growth Strategies in the Bioprocessing Market